Request Demo
Last update 25 Jul 2026
JJH-201601
Last update 25 Jul 2026
Overview
Basic Info
Drug Type Small molecule drug, Liposomal Drug |
Synonyms JJH 201601, JJH-201601, JJH201601 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with JJH-201601CTR20243699
注射用JJH201601脂质体用于治疗晚期胰腺癌、胆道癌和肝细胞癌患者的有效性和安全性的单臂、多中心、开放的Ib/IIa期临床研究
[Translation] A single-arm, multicenter, open-label phase Ib/IIa clinical study on the efficacy and safety of JJH201601 liposomes for injection in the treatment of patients with advanced pancreatic cancer, biliary tract cancer, and hepatocellular carcinoma
ChiCTR2500111729
Single arm, multi center, open phase Ib/IIa clinical study on the efficacy and safety of JJH201601 liposome for injection in the treatment of advanced pancreatic cancer, biliary tract cancer and hepatocellular carcinoma
CTR20232054
注射用 JJH201601 脂质体用于恶性实体瘤患者的安全性、耐受性和药代动力学特性的 I 期研究
[Translation] A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of JJH201601 Liposomes for Injection in Patients with Malignant Solid Tumors
100 Clinical Results associated with JJH-201601
Login to view more data
100 Translational Medicine associated with JJH-201601
Login to view more data
100 Patents (Medical) associated with JJH-201601
Login to view more data
100 Deals associated with JJH-201601
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bile Duct Neoplasms | Phase 2 | China | 21 Oct 2024 | |
| Gallbladder Neoplasms | Phase 2 | China | 21 Oct 2024 | |
| Hepatocellular Carcinoma | Phase 2 | China | 21 Oct 2024 | |
| Pancreatic Ductal Adenocarcinoma | Phase 2 | China | 21 Oct 2024 | |
| Pancreatic Ductal Carcinoma | Phase 2 | China | 21 Oct 2024 | |
| Malignant Solid Neoplasm | Phase 1 | China | 11 Aug 2023 | |
| Advanced Head and Neck Squamous Cell Carcinoma | IND Approval | China | 10 Jul 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free